Distribution of Geriatric Disease-Related Genotypes in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA)

Journal of Epidemiology

Volumn 10, Issue 1 SUPPL., 2000, Pages

  Shimokata, Hiroshi ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Aging; Genotype; Geriatric diseases; Molecular epidemiology

Indexed keywords

ADENOSINE RECEPTOR; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ALLELE; ARTICLE; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; GENETICS; GENOTYPE; GERIATRIC ASSESSMENT; GERIATRICS; HUMAN; JAPAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; AGING; ALLELES; APOLIPOPROTEINS E; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; GERIATRIC ASSESSMENT; GERIATRICS; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, PURINERGIC P1; SEX DISTRIBUTION;

EID: 33845721353     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ambrösone CB, Kadlubar FF. Toward an integrated approach to molecular epidemiology. Am J Epidemiol, 1997:146:912-918.
2. Shpilberg O, Dorman JS, Ferrell RE, Trucco M, Shahar A, Kuller LH. The next stage: molecular epidemiology. J Clin Epidemiol, 1997; 50:633-638.
3. Andrieu N, Goldstein AM. Epidemiologie and genetic approaches in the study of gene-environment interaction: an overview of available methods. Epidemiol Rev, 1998; 20:137-147.
4. Cheung BM, Lau CP, Leung RY, Tan KC. Decrease with age in frequency of the homozygous deletional angiotensin-converting enzyme genotype in hypertensive patients. Clin Experiment Pharmacol Physiol, 1998; 25: 928-931.
5. Frost D, Pfohl M, Clemens P, Haring HU, Beischer W. Evaluation of the insertion/deletion ACE gene polymorphism as a risk factor for carotid artery intima-media thickening and hypertension in young type 1 diabetic patients. Diabetes Care, 1998; 21: 836-840.
6. Pfohl M, Athanasiadis A, Koch M, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is associated with coronary artery plaque calcification as assessed by intravascular ultrasound. J Am Col Cardiol, 1998; 31:987-991.
7. Kario K, Kanai N, Saito K, et al. Ischémie stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation, 1996; 93:1630-1633.
8. Moriyama N, Yamaguchi T, Takeuchi T, et al. Semiquantitative evaluation of a lA-adrenoceptor subtype mRNA in human hypertrophied and non-hypertrophied prostates: regional comparison. Life Sciences, 1999; 64:201-210.
9. Shibata K. Hirasawa A. Moriyama N. Kawabe K. Ogawa S. Tsujimoto G. Eü la-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol, 1996; 118: 1403-1408.
10. Take H, Shibata K, Awaji T, et al. Vascular a 1-adrenoceptor subtype selectivity and a 1-blocker-induced orthostatic hypotension. Jpn J Pharmacol, 1998; 77:61-70.
11. Shibata K, Hirasawa A, Foglar R, Ogawa S, Tsujimoto G. Effects of quinidine and verapamil on human cardiovascular a 1-adrenoceptors. Circulation, 1998; 97: 12271230.
12. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with lateonset familial and sporadic Alzheimer's disease. Neural, 1993;43:1467-1472.
13. Yaffe K, Cauley J, Sands L, Browner W. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arc Neural, 1997; 54: 1110-1114.
14. Shiraki M, Shiraki Y, Aoki C, et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res, 1997; 12:1438-1445.
15. Uusitupa MI, Karhunen L, Rissanen A, et al. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. Am J Clin Nutrition, 1996; 64: 131-136.
16. Inoue H, lannotti CA, Welling CM, et al. Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM). Genomics, 1997; 42: 331-335.
17. Clement K, Vaisse C, Manning BSÜ, et al. Genetic variation in the 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med, 1995; 333: 352-354.
18. Yoshida T. Sakane N. Association between 3adrenoreceptor polymorphism with obesity and diabetes in Japan. Intern Med, 1999; 38:207-209.
19. Richards RJ, Thakur V, Reisin E. Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment. J Human Hypertension, 1996; 10 (Suppl 3): S59-64.
20. Nakano K, Ohta S, Nishimaki K, Miki T, Matsuda S. Alzheimer's disease and DLST genotype. Lancet, 1997; 350: 1367-1368.
21. Sheu KF, Brown AM, Kristal BS, et al. A DLST genotype associated with reduced risk for Alzheimer's disease. Neural, 1999; 52: 1505-1507.
22. Sheu KF, Brown AM, Haroutunian V, et al. Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population. Ann Neural, 1996; 45:48-53.
23. Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor- l gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res, 1998; 13:1569-1576.
24. Yamada Y, Hosoi T, Makimoto F, Tanaka H, Seino Y, Ikeda K. Transforming growth factor -l gene polymorphism and bone mineral density in Japanese adolescents. Am J Med, 1999; 106:477-479.
25. Ichihara S, Yamada Y, Yokota M. Association of a G->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese. Circulation, 1998; 98:1881-1885.
26. Yamada Y, Ichihara S, Fujimura T, Yokota M. Identification of the G99-> T missense mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery dis-ease in Japanese men. Metabolism, 1998; 47:177-181.
27. 279->Phe) is a genetic risk factor for stroke. Stroke, 1997; 28:2417-2420.
28. Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype associated with longevity. Lancet, 1998; 351: 185-186.
29. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucl Acids Res, 1992; 20: 1433.
30. Wenham PR, Price WH, Blundell G. Apolipoprotein E gentyping by one-stage PCR. Lancet, 1991; 337: 11581159.
31. SAS Procedures Guide, Release 6.12 Edition. SAS Institute Inc., Cary, NC, 1997.
32. Khoury MJ. Genetic epidemiology and the future of disease prevention and public health. Epidemiol Rev, 1997; 19: 175-80.
33. Combien F, Costerousse O, Tiret L et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669-676.
34. Takiguchi S, Takata Y, Funakoshi A, et al. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETFrats. Gene, 1997; 197: 169-175.
35. 281->Arg mutation. Biochem Biophy Res Com, 1997; 236:772-775.